Results 121 to 130 of about 480,706 (316)
Gene-mapping study of extremes of cerebral small vessel disease reveals TRIM47 as a strong candidate. [PDF]
Mishra A +67 more
europepmc +1 more source
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Variant-to-gene-mapping analyses reveal a role for pancreatic islet cells in conferring genetic susceptibility to sleep-related traits. [PDF]
Lasconi C +12 more
europepmc +1 more source
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Variant to Gene Mapping to Discover New Targets for Immune Tolerance. [PDF]
Mehra P, Wells AD.
europepmc +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
A Robust and Rapid Candidate Gene Mapping Pipeline Based on M2 Populations. [PDF]
Zhou H +8 more
europepmc +1 more source
Characterization and Molecular Mapping of Genes Determining Semidwarfism in Barley [PDF]
Lynn S. Dahleen +2 more
openalex +1 more source

